UK Begins Study to Look at Length of COVID-19 Quarantine Time
LEXINGTON, Ky. (Sept. 23, 2020) — Beginning this week, some University of Kentucky students living on campus who are in quarantine due to exposure to COVID-19, will be invited to participate in a research study to determine if a testing strategy early during their quarantine is predictive of them remaining negative on day 14 –the typical length for quarantine. Ultimately, the study results could aid in providing more information to determine if this testing strategy could safely shorten the period of quarantine.
The study is among the latest measures taken as part of UK’s START(Screening, Testing and Tracing to Accelerate Restart and Transition) program, according to Dr. Robert DiPaola, team lead of the START program and dean of the UK College of Medicine.
UK students who are in quarantine that are interested in participating in the study will be asked to provide nasal swab samples on days three, five, seven, 10 and 14 of their quarantine, said Jill Kolesar, professor in the UK College of Pharmacy and co-principal investigator for the study.
"The goal is to determine if students testing negative early in quarantine will remain negative on day 14, possibly leading to data that can lessen current protocols for a 14-day quarantine period,” Kolesar said.
About 100 UK students will be enrolled in the first phase of the study which should be completed in about one month, she said.
Results from the UK study will be shared with the CDC for consideration in future protocols and guidelines.
As the state’s flagship, land-grant institution, the University of Kentucky exists to advance the Commonwealth. We do that by preparing the next generation of leaders — placing students at the heart of everything we do — and transforming the lives of Kentuckians through education, research and creative work, service and health care. We pride ourselves on being a catalyst for breakthroughs and a force for healing, a place where ingenuity unfolds. It's all made possible by our people — visionaries, disruptors and pioneers — who make up 200 academic programs, a $476.5 million research and development enterprise and a world-class medical center, all on one campus.